|
Generic Name : Pegaspargase
Pronunciation : peg-AS-par-jase
Therapeutic Classification : Chemotherapy
Trade Name(s):
International- Oncaspar. This medication is an antineoplastic agent, prescribed for acute lymphoblastic leukemia (ALL). When it is not to be taken (Contraindications):
When it is to be taken : IM/IV- The recommended dose is 2,500 IU/m2. How it should be taken : It comes as a solution for injection to be administered by a healthcare provider into the vein or muscle. Special Instruction : * Caution should be exercised in patients with history of liver problems, bone marrow problems, sugar, infection, undergoing radiation therapy, any allergy, who are taking other medications, during pregnancy and breastfeeding. * It may raise blood sugar level; monitor sugar level regularly while taking this medication. * It may reduce platelet counts; avoid injury or bruising. Side Effects : Most Common - Allergic reactions (including anaphylaxis), increased sugar, blood clotting disorder, increase in liver enzyme, inflammation of pancreas, and stroke. * Avoid excess dosage. Storage Conditions : Store it in refrigerator (2 to 8°C), do not freeze it. |
![]() Comment & Contribute
![]()
![]() ![]() | ||


